JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?

  • 0Clinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion +

|

May 6, 2024

|

May 6, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Growth and differentiation factor-15 (GDF-15) shows potential as a biomarker in indolent lymphoproliferative neoplasms (LPN). Elevated GDF-15 levels correlate with beta-2 microglobulin, suggesting its value in assessing disease activity and risk in lymphoma patients.

Area Of Science

  • Oncology
  • Hematology
  • Biochemistry

Background

  • Growth and differentiation factor-15 (GDF-15) is linked to poor prognosis in various cancers and overall mortality.
  • Limited data exists on the role of GDF-15 in lymphoproliferative neoplasms (LPN).
  • This study investigates GDF-15's correlation with LPN activity markers and its clinical utility in lymphoma patients.

Purpose Of The Study

  • To determine the relationship between GDF-15 levels and standard laboratory parameters in LPN.
  • To explore the potential value of GDF-15 assessment in managing lymphoma patients.
  • To analyze GDF-15 changes before and after treatment in indolent LPN.

Main Methods

  • Prospective study involving 40 patients with aggressive/indolent LPN and 31 with indolent LPN on "watch and wait".
  • Serum GDF-15 levels measured using ELISA.
  • Statistical analysis included t-tests, Mann-Whitney, chi-squared tests, and Spearman Rank Order Correlation.

Main Results

  • In indolent lymphoma patients receiving treatment, GDF-15 and fibrinogen levels increased post-therapy (p=0.028 and p=0.001, respectively), while beta-2 microglobulin decreased (p<0.001).
  • GDF-15 showed a positive correlation with beta-2 microglobulin both before (p<0.001) and after (p=0.031) therapy.
  • No significant parameter changes were observed in the "watch and wait" group during the observation period.

Conclusions

  • The positive correlation between GDF-15 and beta-2 microglobulin in indolent LPN patients requiring treatment suggests GDF-15's potential role in risk stratification.
  • GDF-15 may serve as a valuable biomarker for monitoring disease activity in certain lymphoma subtypes.
  • Further research is warranted to fully elucidate the prognostic and diagnostic implications of GDF-15 in lymphoproliferative neoplasms.

Keywords:

Related Concept Videos

Role of Hematopoietic Growth Factors 01:28

1.4K

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

Differentiation of Common Myeloid Progenitor Cells 01:15

3.2K

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

B Cell Activation and Differentiation 01:24

1.7K

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Regulation of Hematopoietic Stem Cells 01:01

3.2K

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Mitogens and the Cell Cycle 02:38

6.5K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

TGF - β Signaling Pathway 01:16

7.3K

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...